EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Extended ambulatory ECG monitoring enhances identification of higher-risk ventricular tachyarrhythmias in patients with hypertrophic cardiomyopathy

Ethan J Rowin, Gaurav Das, Christopher Madias, Mike Hsu, Lori Crosson, Mintu P Turakhia, Barry J Maron, Martin S Maron

Heart Rhythm · 2025-07 · 22 (7) · 1696-1704

DOI: 10.1016/j.hrthm.2024.09.040 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Heart Rhythm, 2025-07. Verfasst von Ethan J Rowin und 7 weiteren Autor:innen. Beteiligte Einrichtung: Hypertrophic Cardiomyopathy Center, Lahey Hospital and Medical Center, Burlington, Massachusetts. Electronic address: Ethan.Rowin@lahey.org. Hauptthemen laut MEDLINE: Cardiomyopathy, Hypertrophic, Electrocardiography, Ambulatory, Tachycardia, Ventricular. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: iRhythm Technologies Inc.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: In hypertrophic cardiomyopathy (HCM), 48-hour ambulatory monitoring has been standard practice to detect nonsustained ventricular tachycardia (NSVT), a sudden death risk marker. Extended-wear ambulatory electrocardiographic (ECG) devices have more recently used for monitoring patients with HCM. OBJECTIVE: We aimed to evaluate NSVT burden identified with continuous ambulatory monitoring for up to 2 weeks compared with initial 48 hours. METHODS: 236 consecutive patients with HCM (49 ± 12 years) underwent 14-day continuous ambulatory monitoring (Zio XT, iRhythm Technologies, San Francisco, CA); diagnostic yield of NSVT compared for initial 48 hours vs extended for 14 days. RESULTS: Of the 236 patients, 114 (48%) had ≥ 1 runs of NSVT (median 2) over 14 days. Median length of NSVT was 7 beats (range: 3 to 67) at rates of 120 to 240 beats per minute (bpm) (median, 167 bpm). In 42 of the 114 patients (37%), initial NSVT occurred ≤ 48 hours and in 72 (63%) only during the extended monitoring period (3 to 14 days). Diagnostic yield for detecting NSVT over 14 days was 2.7-fold greater than ≤ 48 hours (P 200 bpm, ≥ 2 runs in consecutive 2-day period) was identified more frequently during extended monitoring, diagnostic yield over 14 days was 3-fold greater than ≤ 48 hours (P < .001). CONCLUSION: In HCM, NSVT episodes are frequent; however, in most patients, both NSVT and higher-risk NSVT were not detected during initial 48 hours and were confined solely to extended monitoring period. These data support additional clinical studies to evaluate the significance of NSVT on extended monitoring on sudden death risk in HCM.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cardiomyopathy, HypertrophicElectrocardiography, AmbulatoryTachycardia, VentricularHumansMaleFemaleMiddle AgedDeath, Sudden, CardiacRisk AssessmentRisk FactorsFollow-Up StudiesAdultRetrospective Studies

Stichwörter der Autor:innen

Ambulatory Electrocardiographic monitoringHypertrophic cardiomyopathyImplanted cardioverter defibrillatorNonsustained ventricular tachycardiaSudden death

Autor:innen und Institutionen

  • Hypertrophic Cardiomyopathy Center, Lahey Hospital and Medical Center, Burlington, Massachusetts. Electronic address: Ethan.Rowin@lahey.org.
  • Hypertrophic Cardiomyopathy Center, Lahey Hospital and Medical Center, Burlington, Massachusetts.
  • New England Arrhythmia Center, Tufts Medical Center, Boston, Massachusetts.
  • iRhythm Technologies, Inc, San Francisco, California.
  • iRhythm Technologies, Inc, San Francisco, California; Stanford University School of Medicine, Stanford, California.

Förderung

  • iRhythm Technologies Inc

Zitieren

APA

Rowin, E. J., Das, G., Madias, C., Hsu, M., Crosson, L., Turakhia, M. P., Maron, B. J., & Maron, M. S. (2025). Extended ambulatory ECG monitoring enhances identification of higher-risk ventricular tachyarrhythmias in patients with hypertrophic cardiomyopathy. Heart Rhythm, 22(7), 1696-1704. https://doi.org/10.1016/j.hrthm.2024.09.040

Vancouver

Rowin EJ, Das G, Madias C, Hsu M, Crosson L, Turakhia MP, et al. Extended ambulatory ECG monitoring enhances identification of higher-risk ventricular tachyarrhythmias in patients with hypertrophic cardiomyopathy. Heart Rhythm. 2025;22(7):1696-1704. doi:10.1016/j.hrthm.2024.09.040

BibTeX
@article{Rowin2025,
  author = {Rowin, Ethan J and Das, Gaurav and Madias, Christopher and Hsu, Mike and Crosson, Lori and Turakhia, Mintu P and Maron, Barry J and Maron, Martin S},
  title = {Extended ambulatory ECG monitoring enhances identification of higher-risk ventricular tachyarrhythmias in patients with hypertrophic cardiomyopathy},
  journal = {Heart Rhythm},
  year = {2025},
  volume = {22},
  number = {7},
  pages = {1696--1704},
  doi = {10.1016/j.hrthm.2024.09.040}
}
Kostenlos starten →